Form 4: 89bio CEO Rohan Palekar Acquires 5,000 Shares of Common Stock

89bio's Chief Executive Officer, Rohan Palekar, purchased 5,000 shares of the company's common stock at a price of $7.89 per share.

Summary

• Rohan Palekar, the Chief Executive Officer of 89bio, Inc., acquired 5,000 shares of common stock on December 6, 2024.
• The purchase price was $7.89 per share.
• Following this transaction, Mr. Palekar directly owns 471,236 shares of 89bio common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the CEO's purchase of shares can be seen as a sign of confidence, but it's a routine transaction.

Positives

• The CEO's purchase of shares may signal confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transaction is typical for executives who may acquire shares through open market purchases or stock options.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

89bio, Rohan Palekar, insider trading, stock purchase, executive, common stock, ETNB